WO2001002000A3 - Method and composition for affecting reproductive systems - Google Patents

Method and composition for affecting reproductive systems Download PDF

Info

Publication number
WO2001002000A3
WO2001002000A3 PCT/US2000/018249 US0018249W WO0102000A3 WO 2001002000 A3 WO2001002000 A3 WO 2001002000A3 US 0018249 W US0018249 W US 0018249W WO 0102000 A3 WO0102000 A3 WO 0102000A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
reproductive systems
affecting reproductive
affecting
animal
Prior art date
Application number
PCT/US2000/018249
Other languages
French (fr)
Other versions
WO2001002000A9 (en
WO2001002000A2 (en
Inventor
Richard Fayrer-Hosken
Branson W Ritchie
Original Assignee
Univ Georgia Res Found
Fayrer Hosken Richard
Branson W Ritchie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Georgia Res Found, Fayrer Hosken Richard, Branson W Ritchie filed Critical Univ Georgia Res Found
Priority to AU59095/00A priority Critical patent/AU5909500A/en
Priority to CA002378472A priority patent/CA2378472A1/en
Publication of WO2001002000A2 publication Critical patent/WO2001002000A2/en
Publication of WO2001002000A3 publication Critical patent/WO2001002000A3/en
Publication of WO2001002000A9 publication Critical patent/WO2001002000A9/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

An immunogenic composition comprising an immunogen derived from a zona pellucida protein, for control of animal reproduction, treatment of reproductive diseases and disorders, and management of animal behavior.
PCT/US2000/018249 1999-07-01 2000-06-30 Method and composition for affecting reproductive systems WO2001002000A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU59095/00A AU5909500A (en) 1999-07-01 2000-06-30 Method and composition for affecting reproductive systems
CA002378472A CA2378472A1 (en) 1999-07-01 2000-06-30 Method and composition for affecting reproductive systems

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US14230899P 1999-07-01 1999-07-01
US60/142,308 1999-07-01
US17790300P 2000-01-25 2000-01-25
US60/177,903 2000-01-25

Publications (3)

Publication Number Publication Date
WO2001002000A2 WO2001002000A2 (en) 2001-01-11
WO2001002000A3 true WO2001002000A3 (en) 2002-05-10
WO2001002000A9 WO2001002000A9 (en) 2002-08-01

Family

ID=26839964

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/018249 WO2001002000A2 (en) 1999-07-01 2000-06-30 Method and composition for affecting reproductive systems

Country Status (3)

Country Link
AU (1) AU5909500A (en)
CA (1) CA2378472A1 (en)
WO (1) WO2001002000A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1297745T3 (en) 2001-09-26 2008-03-03 Ovagen Internat Ltd Method of producing bird eggs and birds which are specified contamination-free
EP1951283B1 (en) * 2005-11-16 2010-07-14 Pantarhei Bioscience B.V. Pharmaceutical composition for treating or preventing ovarian cancer
CA2643220A1 (en) 2006-02-23 2007-08-30 Leonard Moran Method for incubation and hatching of eggs
RU2436296C2 (en) * 2006-02-23 2011-12-20 Овейджен Интернешнл Лимитед Improved method of obtaining bird's eggs and birds, free of specific microorganisms

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993025231A1 (en) * 1992-06-05 1993-12-23 Dalhousie University Use of zona pellucida glycoproteins for immunocontraception
US5656488A (en) * 1990-11-21 1997-08-12 Washington University Recombinant avirulent salmonella antifertility vaccines
WO2000037100A2 (en) * 1998-12-22 2000-06-29 Dalhousie University Compositions and methods for reducing or preventing fertilization in fish and birds

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656488A (en) * 1990-11-21 1997-08-12 Washington University Recombinant avirulent salmonella antifertility vaccines
WO1993025231A1 (en) * 1992-06-05 1993-12-23 Dalhousie University Use of zona pellucida glycoproteins for immunocontraception
WO2000037100A2 (en) * 1998-12-22 2000-06-29 Dalhousie University Compositions and methods for reducing or preventing fertilization in fish and birds

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
P. WILLIS ET AL.: "Equine immunocontraception using porcine zona pellucida", J. EQUINE VET. SCI., vol. 14, no. 7, 1994, pages 364 - 370, XP000978916 *
Y. TAKEUCHI ET AL.: "A 42kd glycoprotein from chicken egg envelope and avian hololog of the ZPC family in mammalian zona pellucida", EUR. J. BIOCHEM., vol. 260, 1999, pages 736 - 742, XP000978737 *

Also Published As

Publication number Publication date
WO2001002000A9 (en) 2002-08-01
CA2378472A1 (en) 2001-01-11
AU5909500A (en) 2001-01-22
WO2001002000A2 (en) 2001-01-11

Similar Documents

Publication Publication Date Title
AU2002224777A1 (en) Device for controlling, regulating and/or putting an active implant into operation
AU2002332081A1 (en) Method, tool, and system for deploying an implant into the body
AU6853698A (en) Method and device for exposure control, method and device for exposure, and method of manufacture of device
AU6868498A (en) Method, implant, and apparatus for refractive keratoplasty
AU1419199A (en) Flow regulating implant, method of manufacturing, and delivery device
AU7369196A (en) Wireless eeg system for effective auditory evoked response
AU4119899A (en) System for treating the fundus of an eye
AU1692997A (en) Adaptive, performance-optimizing communication system for communicating with an implanted medical device
WO2001006909A3 (en) System and method for attaching soft tissue to bone
IL121625A0 (en) External preparation for topical administration
WO2003049689A3 (en) Isoflavone composition for oral delivery
AU6549898A (en) Method for the broad based treatment of infections, especially infections of organs such as the skin and vagina
AU3842502A (en) Composition for regulating animal growth, method of manufacture and use thereof
AU6365499A (en) Stage device, exposure system, method of device manufacture, and device
AU8965101A (en) Pesticidial composition
AU2621700A (en) Method, device and system for facilitating entry and update of multi-source medical information
AU2001232161A1 (en) System and method for creating, distributing and managing artificial agents
BR9806805B1 (en) solid mixture, and processes for controlling undesirable plant growth and for preparing herbicide formulations.
WO2001002000A3 (en) Method and composition for affecting reproductive systems
WO1997003204A3 (en) (s)-hydroxynitrillyase from hevea brasiliensis
AU2001285835A1 (en) Device and method for raising an animal's hoof
EP1000619A3 (en) Method for treating glaucoma
EP0956856A3 (en) Calcium assimilation accelerator, calcium supplementing diet and method for accelerating calcium assimilation
AU6505898A (en) Sperm extender comprising native phosphocaseinate or beta-lactoglobulin, method for preparing same and uses
AU3637697A (en) Method for reducing the degradability of animal feed protein

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2378472

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 10019643

Country of ref document: US

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

AK Designated states

Kind code of ref document: C2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

COP Corrected version of pamphlet

Free format text: PAGES 1/3-3/3, DRAWINGS, REPLACED BY NEW PAGES 1/3-3/3; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP